The Metastatic Non-Small Cell Lung Cancer market size was valued ~21 billion in 2023 and is anticipated to grow with a ...

According to DelveInsight's analysis, the TROP2 ADC in the NSCLC market landscape is expected to evolve significantly, driven by new opportunities, following the approval of DATROWAY. Additionally ...

Roger Dansey, M.D., formerly Pfizer and Seagen, and Hervé Hoppenot, of Incyte and formerly Novartis Oncology, bring extensive drug development and commercialization expertiseCAMBRIDGE, England & ...